Researcher.Life Logo

Multiple Sclerosis Journal : Impact Factor & More

eISSN: 1477-0970pISSN: 1352-4585

Key Metrics

CiteScore
9.6
H-Index
147
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
1.52
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Multiple Sclerosis Journal

Multiple Sclerosis Journal Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Multiple Sclerosis Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Multiple Sclerosis Journal

Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms through neuroplasticity.
  • 19 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Enteroviral infections with antiCD20 therapies-A class effect?
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapies.
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.
  • 6 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
  • 6 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms through neuroplasticity.
  • 19 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Enteroviral infections with antiCD20 therapies-A class effect?
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapies.
  • 12 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.
  • 6 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)
Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
  • 6 May 2026
  • Multiple sclerosis (Houndmills, Basingstoke, England)

FAQs on Multiple Sclerosis Journal